Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 137, Issue 1, Pages 230-237
Publisher
Wiley
Online
2014-11-27
DOI
10.1002/ijc.29363
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma
- (2014) Chaohui Wu et al. MOLECULAR BIOLOGY REPORTS
- The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma
- (2013) Ashleigh M. Francis et al. ANNALS OF SURGERY
- Classification of Pathologic Response to Neoadjuvant Therapy in Esophageal and Junctional Cancer
- (2013) Claire L. Donohoe et al. ANNALS OF SURGERY
- Circulating miR-200c Levels Significantly Predict Response to Chemotherapy and Prognosis of Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer
- (2013) Koji Tanaka et al. ANNALS OF SURGICAL ONCOLOGY
- Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma
- (2013) N Takeshita et al. BRITISH JOURNAL OF CANCER
- Bile Acids Increase Levels of MicroRNAs 221 and 222, Leading to Degradation of CDX2 During Esophageal Carcinogenesis
- (2013) Juntaro Matsuzaki et al. GASTROENTEROLOGY
- MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response
- (2013) M. Odenthal et al. INTERNATIONAL JOURNAL OF CANCER
- A review of the current understanding and clinical utility of miRNAs in esophageal cancer
- (2013) Naomi S. Sakai et al. SEMINARS IN CANCER BIOLOGY
- Serum miR-21 Expression in Human Esophageal Squamous Cell Carcinomas
- (2012) Er-Hui Cai et al. Asian Pacific Journal of Cancer Prevention
- Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma
- (2012) Youhei Tanaka et al. CANCER
- Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma
- (2012) Junji Kurashige et al. JOURNAL OF SURGICAL ONCOLOGY
- Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
- (2012) P. van Hagen et al. NEW ENGLAND JOURNAL OF MEDICINE
- The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma
- (2011) Tengfei Zhang et al. CLINICAL SCIENCE
- miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
- (2011) M. Garofalo et al. CURRENT MOLECULAR MEDICINE
- Predicting response to neoadjuvant therapy in esophageal cancer
- (2011) Daniel Vallböhmer et al. Expert Review of Anticancer Therapy
- Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
- (2011) Katrin M Sjoquist et al. LANCET ONCOLOGY
- Expression Profile of MicroRNAs in Serum: A Fingerprint for Esophageal Squamous Cell Carcinoma
- (2010) C. Zhang et al. CLINICAL CHEMISTRY
- MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
- (2009) E. A. Mathe et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started